Japan Pharmaceutical Industry will dispose of 22,379 shares of common stock at 4,048 yen per share on August 19, 2026, and will introduce a restricted stock compensation system for directors. The purpose of the disposal is to enhance corporate value and promote shareholder value sharing.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4516","jir_company_name":"Japan Pharmaceutical Industry Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-21","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4516-20260721-01.pdf","jir_short_summary":"Japan Pharmaceutical Industry will dispose of 22,379 shares of common stock at 4,048 yen per share on August 19, 2026, and will introduce a restricted stock compensation system for directors. The purpose of the disposal is to enhance corporate value and promote shareholder value sharing.","jir_summary":"### Disposal Details and Objectives\nJapan Pharmaceutical Industry will dispose of 22,379 shares of common stock at 4,048 yen per share on August 19, 2026. The purpose of the disposal is to promote the ongoing enhancement of corporate value and the sharing of value with shareholders by introducing a remuneration system. A new system will be implemented to allocate restricted stock to directors as a form of compensation, reinforcing incentives while minimizing share dilution. The disposal will be conducted based on a resolution of the Board of Directors, with the disposal price aligned with the market stock price.\n\n### Future Outlook and Impact on Shareholders\nWith this system, target directors will hold shares with transfer restrictions for a certain period, committing to the improvement of corporate value. The disposed shares aim to limit shareholder dilution while enhancing director incentives. Moving forward, the company will appropriately manage the system operations and stock management to ensure sustainable growth and maximize shareholder value.","jir_financial_highlights":"Number of Shares Disposed: 22,379 shares (Unknown)\nDisposal Amount: 90,590,192 yen (Unknown)\nDisposal Price per Share: 4,048 yen (Unknown)","jir_category":"","jir_hashtags":"#JapanPharmaceuticalIndustry, #IRRelated, #JapanStocks","jir_key_figures":"Number of Shares Disposed: 22,379 shares\nDisposal Amount: 90,590,192 yen\nDisposal Price per Share: 4,048 yen","jir_meta_title":"\u3010Japan Pharmaceutical Industry\u3011Share Buyback and Reward System Introduction \uff5c August 2026","jir_meta_description":"Japan Pharmaceutical Industry will dispose of 22,379 shares of its own stock and introduce a restricted stock compensation system for directors in August 2026. The aim is to enhance corporate value.","jir_og_title":"\u3010Japan Pharmaceutical Industry\u3011Share Buyback and Reward System Introduction \uff5c August 2026","jir_og_description":"Japan Pharmaceutical Industry announced share buyback and reward system introduction in August 2026. Aiming to improve corporate value and strengthen director incentives.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7976,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-85995","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n